Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2026-01-02 @ 8:00 AM
Study NCT ID:
NCT02650635
Status:
TERMINATED
Last Update Posted:
2018-09-05
First Post:
2015-12-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-05
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-30
First Submit QC Date:
None
Study First Post Date:
2016-01-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-31
Last Update Post Date:
2018-09-05
Last Update Post Date Type:
ACTUAL